AI & Machine Learning
Jun 16, 2026
Analyst Highlights AI's Potential in Diabetes Management at Medtech Conference
Jun 16, 2026
AI Summary
David Roman, a research analyst at Goldman Sachs, emphasized the important role of AI in diabetes management during a recent medtech conference. Companies like Abbott and Dexcom are leveraging new technologies to assist patients in carbohydrate counting and insulin delivery.
- David Roman is a US medtech and healthcare IT research analyst for Goldman Sachs.
- He stated that AI can play a significant role in helping diabetes patients manage their condition.
- Companies such as Abbott and Dexcom are utilizing new technologies for carbohydrate counting and insulin delivery.
- Roman expressed optimism about innovation in the medtech industry following Goldman Sachs' annual conference.
healthcarediabetesmedtechinnovationAI applications